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In the normal limb, up to the 4th l~anch~ of the lltim an¢or femoral artanes 
were re=Kldy Identified. In the It~-han~ limb, an extan~ive structural remod. 
eling of the vescular netwo~ (l.e, collateral) was observed. Ao~nistmtton of 
Iicotylchoflne Induc~ II ~ dilate1 of ~ intcrovusets In the non~ll 
limb whil~ ~nly II mod(~t dtlat~l in fire i~'h~rnk: limb, MOfl~5~)gic~l asseu- 
merit of collateral ~ r ~  ~ that ~uch i~la~em of va~o~'  
rnporm~ m more evident in coflatm~t~  an umlul~ng app~re~ 
than thoN with a limm~ NX~em'anc~, 
Co~@~=~ 11~ l~mt  ~udy ~ l y  0ocumerttt~ lot tt~e ~m 
tu~ (1) ~ ~othe l lum-d~tmd~ mlmmtior~ of ~ wtlh a m~olw 
t~ l  limit I~low 100 ~ m and (;~} th~ prmmn¢~ of d ~  (mdolt~ium.de~pe~ 
d~t  vam~ma~ mqx.~m~ among maat~m ~ d~in9  ~ ,  
mJcrove~m mac~ty, and may he~ to ~ .ew m~ mgamtn~ me 
coftat~al micmOmula~o 
1 t!81-5,?.| NI1~ 0xki~ !~dkm~ ~ m k ;  ~ o! 
l ' l b -E l~NIo l  
M~m E, Bey~, Ge~g Yu~ H~n~ Mamn ~ t ~ .  &l~k-a~ ~o~a~, 
of the tmal ~=nd m~a~o~. ~ ~ ~ of ~TO.E may ~ 
~ by nmtc o=de (NO). ~ v~y t~m ~ we ~ me 
~ of NO ~ ~ m ~ ~ enms Of es~0m 
In VW~. 
~ ~ ~ rm me ~ of 200 n0~ tT~.E m compared 
w~h ~ ~ and wire ~ v~ me NO Wnmem 
~ L-NAME (100 ,g~0). B,m,v.s measumme~s in me m~act c~s~mn 
q.an~cam~ of myoca~d m~racmy ~ of pmmm vascu~ 
enec~ 
L-N/~E ~ L-N~I~E 
17~l-lE NaCI t7t~JE NaCl 
Ca~tl=ac OUtlp~t 167:10" 108=5 109±2 113¢2 
I ~  tractmn 127 ~: 3" 98±3 104±3 105:=5 
P e ~ ~  71±3" ~±4 93=2 ~2±3 
Iso~oi_ LVSP 97:4  g2±3 ~±I  98±1 
~ drddlm~ 97¢4 102±3 101 ± I 98:=2 
Means ± SEM m % o~ we~hmon v~__ _,,~_." = p < O001 
17p-E mcreasos the can/mc ~ and the eiectmn I~mn due to a 
reduct~n of the aftsdoad. These effects are al0o;,~,e,.i afire ~ 
troth L-NAME. Neither witloJt nor v~ith L-NAME an ~tDlmpc effect of 17,'1-E 
~s ¢lemctab~ in wo.  
Conc/usk~t~s- The hemodynam~ effects of 17p-E due to ~ of ~e 
a~toad am mediated by act~at~g me NO-pamway =nce ml~Z~on of 
NO Wnmes,~ by L-NAME ~ pn~ents the vaso¢~h~Ne ef~=cts of 
17p-E m vwo. 
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i -~"2"~-'1 Soluble Molecule P-Selectln and Adhesion 
Beta-ThromboglobulIn as Markem of Platelet 
Activation In Hypedension 
G.Y.H. Lip, A.D. Blann, I.F. Islim, D.G. Beevem./-/aemostasis Thmmbos~ & 
Vascular Biology Unit. UniverSity Department of Medicine, City Hospital. 
Birmingham. England 
Backgrou;x1: Despite the artana; tree being exposed to high prss~u~eS in hy- 
pertensive pattents, the complications of hypertension (strOkes. hear attacks) 
am paradoxically thmmhet~c rather than haemonhag¢. The coagulation sys- 
tem may thus be impodant in hypertension, leading to a hypercoagulable 
state. 
Aim and Method: To test the hypothesis that the hypercoagulable state 
in hypertension involves platslet activation, we measured 2 platslet activa- 
tion markers, soluble P-selectin and beta thrombogiobulin, by ELISA in two 
studies of untreated patients with hypertension. Levels were compared with 
corrcsponding age- and sex-matched controls. 
Results: Soluble P-selectin levels at a median of 300 ng/mL (range 
190-800 ng/mL) in 100 hypertensive patients (mean BP 162/98 mm Hg), 
were significantly elevated compared to levels in normotensive controls (228 
ng/mL (range 17S-412), p < 0.05), In the ~m¢o~d ~tudy, mean ~ #yore- 
hog. in  ~ were S8 ntyml. (40-?'/) m 40 hypemmmse (l S/101' rm 
Hg). which was I~nt ly  elevated compared to ~ mean of 3~ ng/mL 
(27-,,%) m 2~ cor(ffofs (p < 0.01). Twenty of th~ pat~ntl m i p _ ~  
treated w~th I0 rng qk, na~nl daffy tot 12 w~kl  In an open fNNon. Mean OP 
from 1~/117 mmHg to 151/98 I I~ H 0 ~ ~ p < 0.001), wh~h 
from ~9 ngtmt. (45-106) to 46 n~m~ (3~1-.~) (pllf~d ~ p < 0.0S). 
Co~tm~: In,~'mat~  of 2 mmem oh~m~t ~ m t~x.~ 
t ,m~ mmmml molvt, mm of ~ m m,..m~og~m, w,~ my 
~x,,~m~ to the mmmtx~ m~mm~ ~ hy~tm,  m, ~ ~.  
~W may ~mft~ I~ wamm~ m hyt~ttmme ~ ,  ~."J'.~.,Rh hem~ 
in ~k~l  a¢lwatmn. 
• Po lymofph l lm of  e~( Idgt~ ~ I , ~ m  
S ~ ,  N. Iwai, Y Tl~itn, N ~ ,  Y. Nakamum, M Kmosh~, ~ 
unm~ Of ~v~al  So~x~ Om. Jar~ 
of ~ at amino aod num~ 4e0) ha~ t~en relpo~ed to be morn ram, 
mon mong I~ar~n and French hV~e,em~ m(~,_ ~ Ban amon~ contrail. 
Momo,~. r~x ,m~ms md,~ _~1-~ w~m T ~  h~ t~m mpomm to em~ 
~ ~ ~ ~ m ~d~um behe~o e~d a ~mmm h~ in ~ 
p~mum m mspome to dJum~ tma~nem. In ~e pmmmt n.,dy, we In~S- 
gene and ~ in a .J~pa~se ix~publ~m~ 
~d~ The m, dy pq~n comamd Of ;m3 s~- ts  m~md ~ 
bo,~e~ (8. n = T~). and hypemm~ (HT. n = ~3) gmup~ The cram 
fm NT ~ _h~,~_ pm~'~_ _'re (eP) le~ man 150~0 mmHg and age eto~ S0 
~rs  o1¢1. Theottana lot HTwa= BP moml~m 150~S mmltg. Tha gmotype 
of a __-,~,~,_ .~-m .a~ demmmea by a~ele mmr~ ~ hyl~idizaZk~ 
R~s:  The _fre~_ _,,_,~'y of ere get .n -  Gay,moTto po,'vmoMmm  
sig~fica~ty different among Ihe NT, B, and HT groups (p = 0.0113). Tha GG 
genoq~e Of ltte adduon gen~ m morn common m tt~ NT group (20.4%) 
man m I~e HT group (7.1%). ~ .  ~m T~460 tdlele m mgnlfom~ 
omm hand, ~s  ~ had no s~-T ,~ e~c~ on k~fl venmcu~ 
~ The prom mdy s~0em ma~ G~m)Tm po~mm~sm 
at the a ~  ~=-~ may he involved m ~ ~ of the 
~w-mmn type, among ~ .  
'82-'~7-~ Thmmbomodulin and Tissue Factor Pathway 
Inhibitor Levels as Risk Factom In PMkmls With 
E, mmUal HVpem.=~ 
Th.K. ~akrts, p.G. K ~  G.P. Anastsmadm. T. Dodouras, P. T ~ ,  
AN. Hal2~ahenas, A Pen, akm, M.K. Kynal~]m. ~ Reg. 
B T C ~  La& Del0~ Of ~ / / ( O  Gen. Hosp~al, A~ans. 
Cn~ce 
Back~"  Increased Tmsue Factor Pa~way Inhlbdor ('TFPI) ~ have 
~een rmoru~ m acute ~,~'~.~nic ~ ~ m young mW~Js 
(<40ym). Moreoq~r. ut~,,,~M~-,,~,~In [11d] ~s knowe to have ~hrom~y ~.m 
on b'm~0#k The am~ Of n~s sludy is ~e eveh,,~G~~ of iFf ' i  and TM fe~s 
~ h,nx.~m~uve pahenta t~)m me m~auon of any phamuu:euuc~ mmu.e~ 
and me c:omp~;~ of G-.~e findlngs m me clara dem~d from ~ 
controls. 
Mefhods: Fo~/ mree l~s (23 M, 20 F, age 49-8 ± t0.1, bedy mus 
index 26.6 + 3.9) and forty controls (22 M, 18 F. age 50.1 ± 6.4, BMI 
26.4 + 3.7) w~re included in 1he study. Smokers, oven~ee~lt individuals 
and cl~ahelzcs were e~¢ludecL TFPI and TM leve~s were assayed bY (ELISA) 
an enzyme-I:,nked mm.moassav. ~ sampling was pe~0m~ on 
indndduals at 8-9 am. Sta,aslCal analysis was dor~e with Studenfs t-tesl and 
stsl~sl~al sigr~ficance was su..#.:j~;~l when p < 0.05. 
Results: 
Contro~ p 
TFPI 103.3 + 2828 91.8 • 24 2 10 < 005 
TM 32.5 ± 975 45.6 = 15.17 p < 0.001 
Condus~or~: These, findings 0ncmasod TFPI and decreased TM) tn rela- 
tion with prmnous fir~;r~j~ conceming oh'~er haemostasls parameters, 
port the increased nsk for cardiovascular episodes in hypertensive patients. 
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